This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Shanghai Yao Yuan Biotechnology Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Henri Lichenstein: Innovator in Kawasaki Disease Treatment
Introduction
Henri Lichenstein is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the treatment of Kawasaki disease. His innovative work has led to the development of a patent that addresses a critical health issue.
Latest Patents
Henri Lichenstein holds a patent for "Alpha protein kinase 1 inhibitors for use in treating Kawasaki disease." This patent outlines methods for inhibiting ALPK1 kinase activity using a compound of Formula I. It also includes compositions and methods for therapy, specifically aimed at treating Kawasaki disease. He has 1 patent to his name.
Career Highlights
Lichenstein is associated with Shanghai Yao Yuan Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest to find effective treatments for Kawasaki disease, showcasing his dedication to improving patient outcomes.
Collaborations
Henri collaborates with talented individuals such as Yuning Wei and Danyang Liu. Their combined expertise enhances the innovative environment at Shanghai Yao Yuan Biotechnology Co., Ltd.
Conclusion
Henri Lichenstein's contributions to biotechnology, particularly in the treatment of Kawasaki disease, highlight his role as an influential inventor. His patent and collaborative efforts reflect a commitment to advancing medical science and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile